One such strategy involves the overexpression of Rab27a, a small GTPase critically involved in exosome secretion.[103] Engineering tumor cells to stably overexpress Rab27a significantly increases the yield of exosomes enriched in canonical markers such as CD63 and Hsp70, enhancing their immunostimulatory potential. The gene discussed is RAB27A; the disease is neoplasm.